What is the equity of ABIOMED this year?
ABIOMED has equity of 1.5 B USD this year.
ABIOMED Equity 2025
ABIOMED Equity
1.5 B USD
Ticker
ABMD
ISIN
US0036541003
WKN
873886
In 2025, ABIOMED's equity was 1.5 B USD, a 0% increase from the 0 USD equity in the previous year.
ABIOMED Aktienanalyse
What does ABIOMED do?
Abiomed Inc. is one of the most innovative companies in the medical technology industry. It was founded in 1981 and is headquartered in Danvers, Massachusetts. The company specializes in the development, manufacturing, and marketing of medical devices aimed at saving or improving patients' lives. Abiomed started as a small company focused on implantation technology for cardiac arrhythmias. However, the company soon recognized the need to concentrate on providing solutions for cardiac intensive care. Today, Abiomed is a leader in the field of cardiopulmonary support systems and offers innovative devices to support the heart. Abiomed's business model revolves around leveraging its expertise in medical technology for cardiology interventions and intensive care and bringing innovative products to market. The company has industry experts and doctors on its team who contribute to the development and manufacturing of products. This highest level of professionalism is also reflected in the distribution channels Abiomed utilizes, with a focus on delivering its products to clinics specialized in critical medical interventions. Abiomed is divided into various business segments that concentrate on the medical devices the company offers. One of these segments is the Impella portfolio, which focuses on heart pumps for acute heart failure. These pumps are capable of supporting the heart during cardiological intervention by pumping blood into the heart while artificially ventilating it. The Impella portfolio is recognized as a standard in cardiac intensive care. Another important area for Abiomed is product development. The company heavily invests in researching and developing new products to meet the current demand in cardiology on the market. Abiomed is aware that rapid development of new products can provide a competitive advantage and, therefore, is an essential part of its business model. The technology offered by Abiomed is revolutionary and allows for the treatment of patients with acute heart failure, which was previously difficult or impossible. This is a significant milestone for the company and the healthcare industry in general. Abiomed is aware of its responsibility towards patients, doctors, and hospitals and is continuously working to develop innovative solutions for the healthcare industry. In summary, Abiomed Inc. is a leading company in the medical technology industry that focuses on cardiology intervention and intensive care. The company is innovative and offers products that can save and improve patients' lives. The Impella portfolio, specializing in acute heart failure, is an important part of its business model. Abiomed heavily invests in research and development to consistently provide innovative solutions to its customers. ABIOMED ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing ABIOMED's Equity
ABIOMED's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding ABIOMED's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating ABIOMED's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
ABIOMED's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in ABIOMED’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about ABIOMED stock
What was the equity of ABIOMED compared to the previous year?
The equity of ABIOMED has increased/decreased by 0% decreased compared to the previous year.
What impact does a high equity have on investors of ABIOMED?
A high equity is advantageous for investors of ABIOMED as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of ABIOMED?
A low equity can be a risk for investors of ABIOMED, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of ABIOMED affect the company?
An increase in equity of ABIOMED can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of ABIOMED affect the company?
A reduction in equity of ABIOMED can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of ABIOMED?
Some factors that can affect the equity of ABIOMED include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of ABIOMED so important for investors?
The equity of ABIOMED is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can ABIOMED take to change the equity?
To change equity, ABIOMED can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does ABIOMED pay?
Over the past 12 months, ABIOMED paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ABIOMED is expected to pay a dividend of 0 USD.
What is the dividend yield of ABIOMED?
The current dividend yield of ABIOMED is .
When does ABIOMED pay dividends?
ABIOMED pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of ABIOMED?
ABIOMED paid dividends every year for the past 0 years.
What is the dividend of ABIOMED?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is ABIOMED located?
ABIOMED is assigned to the 'Health' sector.
Wann musste ich die Aktien von ABIOMED kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of ABIOMED from 1/5/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/5/2025.
When did ABIOMED pay the last dividend?
The last dividend was paid out on 1/5/2025.
What was the dividend of ABIOMED in the year 2024?
In the year 2024, ABIOMED distributed 0 USD as dividends.
In which currency does ABIOMED pay out the dividend?
The dividends of ABIOMED are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The ABIOMED stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von ABIOMED
Our stock analysis for ABIOMED Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ABIOMED Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
